Sarah Kidd

Dr Sarah Kidd

Adjunct Senior Lecturer

School of Biological Sciences

Faculty of Sciences, Engineering and Technology

Sarah Kidd is Head of the National Mycology Reference Centre at SA Pathology, Adelaide, as well as Adjunct Senior Lecturer at the University of Adelaide. She completed a Bachelor of Medical Science with Honours, and a PhD in Medicine, both at the University of Sydney. She holds Fellowships of the Australian Society for Microbiology, and of the European Confederation of Medical Mycology. Research interests include the epidemiology, phylogeny, and antifungal susceptibilities of fungal pathogens.

Please note correct email address: SARAH.KIDD@SA.GOV.AU

  • Appointments
    Date Position Institution name
    2012 - ongoing Adjunct Senior Lecturer University of Adelaide
    2011 - ongoing Head, National Mycology Reference Centre SA Pathology
    2006 - 2010 Postdoctoral Research Scientist Monash University, Melbourne
    2003 - 2006 Postdoctoral Research Scientist University of British Columbia

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2023 Fellowship Fellow of the European Confederation of Medical Mycology ECMM Australia -
    2023 Award Howard Morris Quality Use of Pathology Award SA Pathology Australia -
    2018 Fellowship Fellowship of the Australian Society for Microbiology Australian Society for Microbiology Australia -

  • Education
    Date Institution name Country Title
    2000 - 2003 University of Sydney Australia PhD
    1996 - 1999 University of Sydney Australia Bachelor of Medical Science (Hons.)

  • Postgraduate Training
    Date Title Institution Country
    2006 - 2010 Research Fellow Monash University, Alfred Hospital Australia
    2003 - 2006 Postdoctoral Research Fellow University of British Columbia Canada

  • Research Interests
    Mycology

  • Journals
    Year Citation
    2024 Birnie, J. D., Ahmed, T., Kidd, S. E., Westall, G. P., Snell, G. I., Peleg, A. Y., & Morrissey, C. O. (2024). Multi-Locus Microsatellite Typing of Colonising and Invasive Aspergillus fumigatus Isolates from Patients Post Lung Transplantation and with Chronic Lung Disease. Journal of Fungi, 10(2), 19 pages.
    DOI
    2024 Kidd, S. E., Hagen, F., Halliday, C. L., Abdolrasouli, A., Boekhout, T., Crous, P. W., . . . Chen, S. C. A. (2024). Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion. Journal of clinical microbiology, 62(4), e0157023.
    DOI
    2024 Neoh, C. F., Chen, S. C. -A., Lanternier, F., Tio, S. Y., Halliday, C. L., Kidd, S. E., . . . Slavin, M. A. (2024). Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections. CLINICAL MICROBIOLOGY REVIEWS, 75 pages.
    DOI
    2023 Tio, S. Y., Chen, S. C. A., Hamilton, K., Heath, C. H., Pradhan, A., Morris, A. J., . . . Slavin, M. A. (2023). Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020. The Lancet Regional Health - Western Pacific, 40, 100888.
    DOI Scopus1
    2023 Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023). An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Review of Molecular Diagnostics, 23(12), 1135-1152.
    DOI Scopus3 Europe PMC3
    2023 Kidd, S. E., Abdolrasouli, A., & Hagen, F. (2023). Fungal Nomenclature: Managing Change is the Name of the Game. OPEN FORUM INFECTIOUS DISEASES, 10(1), 15 pages.
    DOI Europe PMC16
    2023 Kidd, S. E., Abdolrasouli, A., & Hagen, F. (2023). Reply to "re: Fungal Nomenclature: Managing Change Is the Name of the Game". Open Forum Infectious Diseases, 10(8), 1 page.
    DOI
    2023 O’hern, J. A., Koenen, A., Janson, S., Hajkowicz, K. M., Robertson, I. K., Kidd, S. E., . . . Ralph, A. P. (2023). Epidemiology, management and outcomes of Cryptococcus gattii infections: A 22-year cohort. PLoS Neglected Tropical Diseases, 17(3), e0011162.
    DOI Scopus1
    2022 Lamont-Friedrich, S. J., Kidd, S. E., Giles, C., Griesser, H. J., & Coad, B. R. (2022). Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin. Medical Mycology, 60(1), 4 pages.
    DOI WoS1
    2022 Kidd, S. E., Halliday, C. L., Haremza, E., Gardam, D. J., Chen, S. C. A., & Elvy, J. A. (2022). Attitudes of Australasian Clinicians and Laboratory Staff to Changing Fungal Nomenclature: Has Mycological Correctness Really Gone Mad?. Microbiology Spectrum, 10(1), 6 pages.
    DOI Scopus5 WoS6 Europe PMC5
    2022 Kidd, S. E., & Weldhagen, G. F. (2022). Diagnosis of dermatophytes: from microscopy to direct PCR. Microbiology Australia, 43(1), 9-13.
    DOI Scopus5 WoS5
    2022 Crawford, L. C., Kidd, S. E., Anninos, T. M., Turra, M., & Weldhagen, G. F. (2022). Candida auris PCR for high-throughput infection control screening. Medical Mycology, 60(8), 6 pages.
    DOI Scopus3 WoS3 Europe PMC2
    2022 Halliday, C. L., Weeks, K., Farac, K., Alexiou, H., Green, W., Lopez, R., . . . Kidd, S. E. (2022). Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories. Pathology, 54(7), 922-927.
    DOI Scopus1 Europe PMC1
    2021 Kay, A., Boland, L., Kidd, S. E., Beatty, J. A., Talbot, J. J., & Barrs, V. R. (2021). Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic Aspergillus species in section Fumigati. Medical Mycology Case Reports, 34, 13-17.
    DOI Scopus4 WoS3 Europe PMC3
    2021 Teo, T. S. P., Crawford, L. C., Pilch, W. T., Carney, B., Solanki, N., Kidd, S. E., & Warner, M. S. (2021). Mycetoma caused by Microsporum canis in a patient with renal transplant: A case report and review of the literature. Transplant Infectious Disease, 23(3), 6 pages.
    DOI Scopus2 WoS17 Europe PMC1
    2021 Kidd, S. E., Halliday, C. L., McMullan, B., Chen, S. C. A., & Elvy, J. (2021). New names for fungi of medical importance: Can we have our cake and eat it too?. Journal of Clinical Microbiology, 59(3), 2 pages.
    DOI Scopus15 WoS12 Europe PMC11
    2021 Keighley, C. L., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., . . . Chen, S. C. A. (2021). Risk factors for candidaemia: A prospective multi-centre case-control study. Mycoses, 64(3), 257-263.
    DOI Scopus19 WoS15 Europe PMC13
    2021 Kidd, S. E., Crawford, L. C., & Halliday, C. L. (2021). Antifungal Susceptibility Testing and Identification. Infectious Disease Clinics of North America, 35(2), 313-339.
    DOI Scopus14 WoS10 Europe PMC9
    2021 Khanina, A., Tio, S. Y., Ananda-Rajah, M. R., Kidd, S. E., Williams, E., Chee, L., . . . Thursky, K. A. (2021). Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021. Internal Medicine Journal, 51(S7), 18-36.
    DOI Scopus15 WoS12 Europe PMC4
    2020 Kidd, S. E., Chen, S. C. A., Meyer, W., & Halliday, C. L. (2020). A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?. Frontiers in Microbiology, 10, 20 pages.
    DOI Scopus99 WoS80 Europe PMC58
    2020 Ross, I. L., Weldhagen, G. F., & Kidd, S. E. (2020). Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay. Pathology, 52(4), 473-477.
    DOI Scopus13 WoS9 Europe PMC3
    2020 Davidson, N., Campbell, K., Foroughi, F., Tayal, V., Lynar, S., Crawford, L. C., . . . Meumann, E. M. (2020). Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature. BMC Infectious Diseases, 20(1), 5 pages.
    DOI
    2019 Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Botterel, F., Canton, E., Castro, C., . . . Tejada, M. (2019). Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods. Antimicrobial Agents and Chemotherapy, 63(1), 15 pages.
    DOI Scopus56 WoS44 Europe PMC31
    2019 Marshall, A. C., Kidd, S. E., Lamont-Friedrich, S. J., Arentz, G., Hoffmann, P., Coad, B. R., & Bruning, J. B. (2019). Structure, mechanism, and inhibition of aspergillus fumigatus thioredoxin reductase. Antimicrobial Agents and Chemotherapy, 63(3), 1-15.
    DOI Scopus27 WoS25 Europe PMC12
    2019 Thomson, J., Trott, D. J., Malik, R., Galgut, B., McAllister, M. M., Nimmo, J., . . . Kidd, S. E. (2019). An atypical cause of sporotrichosis in a cat. Medical Mycology Case Reports, 23, 72-76.
    DOI Scopus17 WoS16 Europe PMC9
    2019 Keighley, C., Chen, S. C. A., Marriott, D., Pope, A., Chapman, B., Kennedy, K., . . . Slavin, M. A. (2019). Candidaemia and a risk predictive model for overall mortality: A prospective multicentre study. BMC Infectious Diseases, 19(1), 10 pages.
    DOI Scopus34 WoS24 Europe PMC20
    2019 Hossain, M. A., Biva, I. J., Kidd, S. E., Whittle, J. D., Griesser, H. J., & Coad, B. R. (2019). Antifungal activity in compounds from the Australian desert plant Eremophila alternifolia with potency against Cryptococcus spp. Antibiotics, 8(2), 34-1-34-12.
    DOI Scopus8 WoS6 Europe PMC3
    2019 Chew, S. M., Sweeney, N., Kidd, S. E., & Reed, C. (2019). Candida auris arriving on our shores: an Australian microbiology laboratory's experience. Pathology, 51(4), 431-433.
    DOI Scopus6 WoS5 Europe PMC2
    2019 New, D., Beukers, A. G., Kidd, S. E., Merritt, A. J., Weeks, K., Van Hal, S. J., & Arthur, I. (2019). Identification of multiple species and subpopulations among Australian clinical Sporothrix isolates using whole genome sequencing. Medical Mycology, 57(7), 905-908.
    DOI Scopus14 WoS12 Europe PMC8
    2019 Meyer, W., Arthur, I., Ellis, D., Kan, A., Kidd, S., Maszewska, K., & Weeks, K. (2019). Australian medical mycology culture collections: Fundamental resources for mycological diagnosis and research. Microbiology Australia, 40(3), 130-134.
    DOI
    2019 Ong, C. W., Chen, S. C. A., Clark, J. E., Halliday, C. L., Kidd, S. E., Marriott, D. J., . . . Heath, C. H. (2019). Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Internal Medicine Journal, 49(10), 1229-1243.
    DOI Scopus38 WoS24 Europe PMC15
    2019 Biswas, C., Marcelino, V., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. (2019). Corrigendum: Whole genome sequencing of australian candida glabrata isolates reveals genetic diversity and novel sequence types (Front. Microbiol., (2018), 9, (2946), 10.3389/fmicb.2018.02946). Frontiers in Microbiology, 10(SEP), 2218.
    DOI
    2019 Talbot, J. J., Frisvad, J. C., Meis, J. F., Hagen, F., Verweij, P. E., Hibbs, D. E., . . . Houbraken, J. (2019). Cyp51A mutations, extrolite profiles, and antifungal susceptibility in clinical and environmental isolates of the aspergillus viridinutans species complex. Antimicrobial Agents and Chemotherapy, 63(11), 13 pages.
    DOI Scopus17 WoS16 Europe PMC9
    2019 Pérez-Hansen, A., Lass-Flörl, C., Lackner, M., Aigner, M., Alastruey-Izquierdo, A., Arikan-Akdagli, S., . . . Willinger, B. (2019). Antifungal susceptibility profiles of rare ascomycetous yeasts. Journal of Antimicrobial Chemotherapy, 74(9), 2649-2656.
    DOI Scopus19 WoS17 Europe PMC13
    2018 Bennett, P. F., Talbot, J. J., Martin, P., Kidd, S. E., Makara, M., & Barrs, V. R. (2018). Long term survival of a dog with disseminated Aspergillus deflectus infection without definitive treatment. Medical Mycology Case Reports, 22, 1-3.
    DOI Scopus5 WoS4 Europe PMC3
    2018 Marinelli, T., Kidd, S., Shaw, D., & Rowe, E. (2018). Aspergillus fumigatus endocarditis in an indigenous Australian male without classic risk factors. Medical Mycology Case Reports, 22, 61-64.
    DOI Scopus4 WoS3 Europe PMC3
    2018 Kidd, S. E., Halliday, C. L., Morris, A. J., & Chen, S. C. A. (2018). Antifungal susceptibility testing in Australasian clinical laboratories: we must improve our performance. Pathology, 50(3), 257-260.
    DOI Scopus6 WoS6
    2018 Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Dannaoui, E., Garcia-Effron, G., Guinea, J., . . . Tortorano, A. M. (2018). Posaconazole MIC distributions for aspergillus fumigatus species complex by four methods: Impact of cyp51a mutations on estimation of epidemiological cutoff values. Antimicrobial Agents and Chemotherapy, 62(4), 11 pages.
    DOI Scopus33 WoS26 Europe PMC14
    2018 Biswas, C., Marcelino, V. R., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. C. A. (2018). Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types. Frontiers in Microbiology, 9, 12 pages.
    DOI Scopus29 WoS24 Europe PMC26
    2017 Talbott, J. J., Houbraken, J., Frisvad, J. C., Samson, R. A., Kidd, S., Pitt, J., . . . Barrs, V. R. (2017). Discovery of Aspergillus frankstonensis sp. nov. during
    environmental sampling for animal and human fungal pathogens. PLoS ONE, 12(8), e0181660-1-e0181660-17.
    DOI Scopus13 WoS12 Europe PMC8
    2017 Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, R., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). Multicenter, International Study of MIC/ MEC Distributions for definition of epidemiological cutoff values for sporothrix species identified by molecular methods. Antimicrobial Agents and Chemotherapy, 61(10), e01057-17-1-e01057-17-8.
    DOI Scopus73 WoS51 Europe PMC50
    2017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Changing epidemiology of candidaemia in Australia.. The Journal of antimicrobial chemotherapy, 72(4), 1103-1108.
    DOI Scopus117 WoS96 Europe PMC60
    2017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422. Journal of Antimicrobial Chemotherapy, 72(4), 1270.
    DOI Scopus29 WoS36 Europe PMC28
    2016 Lategan, M. J., Klare, W., Kidd, S., Hose, G. C., & Nevalainen, H. (2016). The unicellular fungal tool RhoTox for risk assessments in groundwater systems. Ecotoxicology and Environmental Safety, 132, 18-25.
    DOI Scopus9 WoS6 Europe PMC3
    2016 McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia. BMC Infectious Diseases, 16(1), 1-7.
    DOI Scopus26 WoS21 Europe PMC14
    2016 Morton, C. O., White, P. L., Barnes, R. A., Klingspor, L., Cuenca-Estrella, M., Lagrou, K., . . . Loeffler, J. (2016). Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus ?. Medical Mycology, 55(4), myw093.
    DOI Scopus34 WoS27 Europe PMC22
    2016 Morris, A. J., Arthur, I. H., Kidd, S. E., Halliday, C. L., Meyer, W., Robson, J. M., . . . Haremza, E. (2016). Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvement. Pathology, 48(6), 531-534.
    DOI Scopus5 WoS5 Europe PMC2
    2016 Kennedy, K. J., Daveson, K., Slavin, M. A., van Hal, S. J., Sorrell, T. C., Lee, A., . . . Chen, S. C. A. (2016). Mucormycosis in Australia: Contemporary epidemiology and outcomes. Clinical Microbiology and Infection, 22(9), 775-781.
    DOI Scopus78 WoS64 Europe PMC47
    2016 Espinel-Ingroff, A., Colombo, A., Cordoba, S., Dufresne, P., Fuller, J., Ghannoum, M., . . . Turnidge, J. (2016). International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrobial Agents and Chemotherapy, 60(2), 1079-1084.
    DOI Scopus111 WoS99 Europe PMC65
    2016 Halliday, C., Chen, S., Kidd, S., van Hal, S., Chapman, B., Heath, C., . . . Slavin, M. (2016). Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. International Journal of Antimicrobial Agents, 48(4), 453-458.
    DOI Scopus22 WoS22 Europe PMC9
    2015 Slavin, M., van Hal, S., Sorrell, T., Lee, A., Marriott, D., Daveson, K., . . . Chambers, S. (2015). Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clinical Microbiology and Infection, 21(5), 490.e1-490.e10.
    DOI Scopus129 WoS100 Europe PMC73
    2015 Halliday, C. L., Kidd, S. E., Sorrell, T. C., & Chen, S. C. A. (2015). Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?. Pathology, 47(3), 257-269.
    DOI Scopus40 WoS33 Europe PMC24
    2015 van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., . . . Verweij, P. E. (2015). Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21(6), 1041-1044.
    DOI Scopus290 WoS260 Europe PMC194
    2015 Espinel-Ingroff, A., & Kidd, S. E. (2015). Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infection and Drug Resistance, 8, 89-97.
    DOI Scopus42 WoS39 Europe PMC27
    2015 Talbot, J. J., Kidd, S. E., Martin, P., Beatty, J. A., & Barrs, V. R. (2015). Azole resistance in canine and feline isolates of Aspergillus fumigatus. Comparative Immunology, Microbiology and Infectious Diseases, 42, 37-41.
    DOI Scopus16 WoS8 Europe PMC6
    2015 Kidd, S. E., Goeman, E., Meis, J. F., Slavin, M. A., & Verweij, P. E. (2015). Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses, 58(6), 350-355.
    DOI Scopus89 WoS79 Europe PMC61
    2015 Gardiner, B. J., Simpson, I., Khuu, M. H., Kidd, S. E., Lo, C. H., & Jenkin, G. A. (2015). An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae. Medical Mycology Case Reports, 7, 8-11.
    DOI Scopus4 WoS3 Europe PMC4
    2015 Espinel-Ingroff, A., Chakrabarti, A., Chowdhary, A., Cordoba, S., Dannaoui, E., Dufresne, P., . . . Turnidge, J. (2015). Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrobial Agents and Chemotherapy, 59(3), 1745-1750.
    DOI Scopus93 WoS72 Europe PMC56
    2015 Espinel-Ingroff, A., Alvarez-Fernandez, M., Cantón, E., Carver, P., Chen, S., Eschenauer, G., . . . Turnidge, J. (2015). Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrobial Agents and Chemotherapy, 59(11), 6725-6732.
    DOI Scopus56 WoS52 Europe PMC37
    2015 Brischetto, A., Kidd, S., & Baird, R. (2015). Case report: First reported Australian case of Cladophilophora arxii: Features consistent with possible primary pulmonary chromoblastomycosis. American Journal of Tropical Medicine and Hygiene, 92(4), 791-793.
    DOI Scopus5 WoS5 Europe PMC3
    2015 Khoury, S., Kidd, S., & Warren, L. (2015). Neonatal tinea corporis due to a novel strain of Trichophyton rubrum. Australasian Journal of Dermatology, 56(4), 311-312.
    DOI Scopus4 WoS3 Europe PMC3
    2015 Kidd, S., Halliday, C., & Ellis, D. (2015). The role of clinical mycology reference laboratories. Microbiology Australia, 36(2), 64-66.
    DOI
    2014 Subedi, S., Kidd, S. E., Baird, R. W., Coatsworth, N., & Ralph, A. P. (2014). Case Report: Sporotrichosis from the northern territory of Australia. American Journal of Tropical Medicine and Hygiene, 91(6), 1263-1268.
    DOI Scopus6 WoS7 Europe PMC3
    2014 Macesic, N., Fleming, S., Kidd, S., Madigan, V., Chean, R., Ritchie, D., & Slavin, M. (2014). Protothecosis in hematopoietic stem cell transplantation: Case report and review of previous cases. Transplant Infectious Disease, 16(3), 490-495.
    DOI Scopus18 WoS15 Europe PMC10
    2014 Talbot, J. J., Johnson, L. R., Martin, P., Beatty, J. A., Sutton, D. A., Billen, F., . . . Barrs, V. R. (2014). What causes canine sino-nasal aspergillosis? A molecular approach to species identification. Veterinary Journal, 200(1), 17-21.
    DOI Scopus18 WoS16 Europe PMC11
    2014 Coad, B., Kidd, S., Ellis, D., & Griesser, H. (2014). Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. Biotechnology Advances, 32(2), 296-307.
    DOI Scopus62 WoS54 Europe PMC20
    2013 Chen, S. C. A., Korman, T. M., Slavin, M. A., Marriott, D., Byth, K., Bak, N., . . . Sorrell, T. C. (2013). Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clinical Infectious Diseases, 57(4), 543-551.
    DOI Scopus101 WoS85 Europe PMC67
    2013 Barrs, V., van Doorn, T., Houbraken, J., Kidd, S., Martin, P., Pinheiro, M., . . . Samson, R. (2013). Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE, 8(6), e64871-1-e64871-11.
    DOI Scopus88 WoS77 Europe PMC47
    2013 Holmes, N. E., Trevillyan, J. M., Kidd, S. E., & Leong, T. Y. M. (2013). Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma. Medical Mycology Case Reports, 2(1), 98-102.
    DOI Scopus13 WoS10 Europe PMC8
    2012 Bartlett, K. H., Cheng, P. Y., Duncan, C., Galanis, E., Hoang, L., Kidd, S., . . . Kronstad, J. (2012). A Decade of Experience: Cryptococcus gattii in British Columbia. Mycopathologia, 173(5-6), 311-319.
    DOI Scopus60 WoS53 Europe PMC46
    2012 Chen, S. C. A., Slavin, M. A., Heath, C. H., Geoffrey Playford, E., Byth, K., Marriott, D., . . . Sorrell, T. C. (2012). Clinical manifestations of cryptococcus gattii infection: Determinants of neurological sequelae and death. Clinical Infectious Diseases, 55(6), 789-798.
    DOI Scopus153 WoS132 Europe PMC105
    2012 Espinel-Ingroff, A., Aller, A., Canton, E., Castanon-Olivares, L., Chowdhary, A., Cordoba, S., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole. Antimicrobial Agents and Chemotherapy, 56(11), 5898-5906.
    DOI Scopus201 WoS188 Europe PMC147
    2012 Espinel-Ingroff, A., Chowdhary, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Hagen, F., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine. Antimicrobial Agents and Chemotherapy, 56(6), 3107-3113.
    DOI Scopus123 WoS111 Europe PMC84
    2011 D'Souza, C. A., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., . . . Cuomoe, C. A. (2011). Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. mBio, 2(1), 11 pages.
    DOI Scopus161 WoS146 Europe PMC120
    2010 Galanis, E., Macdougall, L., Kidd, S., Morshed, M., & British Columbia Cryptococcus gattii Working Group. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.. Emerging infectious diseases, 16(2), 251-257.
    DOI Europe PMC151
    2010 Galanis, E., & MacDougall, L. (2010). Epidemiology of <i>Cryptococcus gattii</i>, British Columbia, Canada, 1999-2007. EMERGING INFECTIOUS DISEASES, 16(2), 251-257.
    DOI WoS194
    2009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
    DOI WoS184 Europe PMC145
    2009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
    DOI WoS184 Europe PMC145
    2009 Kidd, S. E., Ling, L. M., Meyer, W., Morrissey, C. O., Chen, S. C. A., & Slavin, M. A. (2009). Molecular epidemiology of invasive aspergillosis: Lessons learned from an outbreak investigation in an Australian hematology unit. Infection Control and Hospital Epidemiology, 30(12), 1223-1226.
    DOI Scopus14 WoS11 Europe PMC8
    2009 Kidd, S. E., Nik Zulkepeli, N. A. A., Slavin, M. A., & Morrissey, C. O. (2009). Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications. Journal of Microbiological Methods, 78(2), 223-226.
    DOI Scopus16 WoS13 Europe PMC11
    2009 Hurst, S. F., Kidd, S. E., Morrissey, C. O., Snelders, E., Melchers, W. J. G., Castelli, M. V., . . . Arunmozhi Balajee, S. (2009). Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus. Journal of Clinical Microbiology, 47(5), 1562-1564.
    DOI Scopus14 WoS13 Europe PMC8
    2008 Bartlett, K. H., Kidd, S. E., & Kronstad, J. W. (2008). The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1), 58-65.
    DOI Scopus86 Europe PMC65
    2007 Upton, A., Fraser, J. A., Kidd, S. E., Bretz, C., Bartlett, K. H., Heitman, J., & Marr, K. A. (2007). First contemporary case of human infection with Cryptococcus gattii in puget sound: Evidence for spread of the Vancouver Island outbreak. Journal of Clinical Microbiology, 45(9), 3086-3088.
    DOI Scopus70 WoS64 Europe PMC54
    2007 Kidd, S. E., Bach, P. J., Hingston, A. O., Mak, S., Chow, Y., MacDougall, L., . . . Bartlett, K. H. (2007). Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerging Infectious Diseases, 13(1), 51-57.
    DOI Scopus113 WoS98 Europe PMC79
    2007 MacDougall, L., Kidd, S. E., Galanis, E., Mak, S., Leslie, M. J., Cieslak, P. R., . . . Bartlett, K. H. (2007). Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerging Infectious Diseases, 13(1), 42-50.
    DOI Scopus235 WoS202 Europe PMC149
    2007 Kidd, S. E., Chow, Y., Mak, S., Bach, P. J., Chen, H., Hingston, A. O., . . . Bartlett, K. H. (2007). Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Applied and Environmental Microbiology, 73(5), 1433-1443.
    DOI Scopus187 WoS178 Europe PMC137
    2006 Filion, T., Kidd, S., & Aguirre, K. (2006). Isolation of Cryptococcus laurentii from Canada Goose guano in rural upstate New York. Mycopathologia, 162(5), 363-368.
    DOI Scopus13 WoS12 Europe PMC7
    2005 Kidd, S. E., Guo, H., Bartlett, K. H., Xu, J., & Kronstad, J. W. (2005). Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryotic Cell, 4(10), 1629-1638.
    DOI Scopus92 WoS95 Europe PMC69
    2004 Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., . . . Meyer, W. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17258-17263.
    DOI Scopus614 WoS563 Europe PMC446
    2004 Igreja, R. P., Dos Santos Lazéra, M., Wanke, B., Gutierrez Galhardo, M. C., Kidd, S. E., & Meyer, W. (2004). Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Medical Mycology, 42(3), 229-238.
    DOI Scopus48 WoS47 Europe PMC41
    2004 Katsu, M., Kidd, S., Ando, A., Moretti-Branchini, M. L., Mikami, Y., Nishimura, K., & Meyer, W. (2004). The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research, 4(4-5), 377-388.
    DOI Scopus96 WoS97 Europe PMC76
    2003 Kidd, S. E., Sorrell, T. C., & Meyer, W. (2003). Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Medical Mycology, 41(2), 171-176.
    DOI Scopus37 WoS33 Europe PMC20

  • Books
    Year Citation
    2022 Kidd, S., Halliday, C., & Ellis, D. (2022). Descriptions of Medical Fungi. CABI.
    DOI
    2016 Kidd, S., Halliday, C., Alexiou, H., & Ellis, D. (2016). Descriptions of Medical Fungi Third Edition.

  • Book Chapters
    Year Citation
    2022 Hilmarsdóttir, I., Kidd, S., & Lau, A. (2022). Chapter 87: Mycology. In N. Rifai (Ed.), Tietz Textbook of Laboratory Medicine - E-Book (7th ed.). Elsevier Health Sciences.
    2019 Kidd, S. E. (2019). Cryptococcosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association.
    DOI
    2019 Kidd, S. E., & Arthur, I. (2019). Sporotrichosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association.
    DOI
    2018 Halliday, C. L., & Kidd, S. E. (2018). Cryptococcus species. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 80-82). Oxford University Press.
    DOI
    2018 Kidd, S. E., & Halliday, C. H. (2018). Dematiaceous fungi. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 88-92). UK: Oxford University Press.
    DOI
    - Bartlett, K., Byrnes, E., Duncan, C., Fyfe, M., Galanis, E., Heitman, J., . . . Kronstad, J. (n.d.). The Emergence of <i>Cryptococcus gattii</i> Infections on Vancouver Island and Expansion in the Pacific Northwest. In Cryptococcus (pp. 313-325). ASM Press.
    DOI

  • Conference Papers
    Year Citation
    2021 Crawford, L., Turra, M., Kidd, S., & Weldhagen, G. (2021). Candida auris PCR for high throughput infection control screening. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia.
    2021 Crawford, L., & Kidd, S. (2021). Simple detection and differentiation of Candida auris on CHROMagar Candida Plus agar. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia.
    2019 Crawford, L. C., Tam, P., Kidd, S., & Nelson, R. (2019). Scopulariopsis gracilis septic arthritis in an immunocompromised host. In Mycology Masterclass. Kingscliff, NSW, Australia.
    2016 McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological Investigation Of An Outbreak Of Sporotrichosis. In INTERNAL MEDICINE JOURNAL Vol. 46 (pp. 12-13). WILEY-BLACKWELL.
    DOI
    2014 Viiret, E., Birader, M., Holmes, M., Kidd, S., & Holmes-Liew, C. (2014). UTILITY OF BRONCHOALVEOLAR LAVAGE GALACTOMANNAN IN DIAGNOSIS OF ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. In RESPIROLOGY Vol. 19 (pp. 127). WILEY-BLACKWELL.
    2012 Chen, S., Slavin, M., Heath, C., Playford, E. G., Byth, K., Marriott, D., . . . Sorrell, T. (2012). <i>Cryptococcus gattii</i> infection: Long term morbidity and determinants of neurological sequelae and death. In MYCOSES Vol. 55 (pp. 78). WILEY-BLACKWELL.
    2007 Galanis, E., MacDougall, L., Li, M., Kidd, S., Lee, M., & Morshed, M. (2007). Clinical and epidemiological aspects of locally-acquired <i>Cryptococcus gattii</i> human infections, an emerging fungal pathogen in British Columbia, Canada. In INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS Vol. 29 (pp. S34-S35). Munich, GERMANY: ELSEVIER SCIENCE BV.
    DOI
    2004 Bartlett, K. H., MacDougall, L., Mak, S., Duncan, C., Kidd, S., & Fyfe, M. (2004). Cryptococcus gattii, a tropical pathogen emerging in a temperate climate zone. In 16th Conference on Biometeorology and Aerobiology (pp. 39-43).
    Scopus1

  • Conference Items
    Year Citation
    2019 Nelson, R., Crawford, L., Kidd, S., & Tam, P. C. K. (2019). Scopulariopsis gracilis septic arthritis. Poster session presented at the meeting of Mycology Master Class.
    2017 Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, D., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). International evaluation of CLSI MIC/MEC distributions for definition of epidemiological cutoff values (ECVs) for species of Sporothrix identified by molecular methods. Poster session presented at the meeting of MYCOSES. WILEY.
    2013 Birader, M. I., Kidd, S., & Holmes-Liew, C. -L. (2013). OPTIMAL UTILITY OF BAL FLUID GALACTOMANNAN IN DIAGNOSING INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL.
    2013 Birader, M. I., Holmes, M. D., Kidd, S., & Holmes-Liew, C. L. (2013). Utility of bronchoalveolar lavage galactomannan in diagnosis of Aspergillosis in lung transplant recipients. Poster session presented at the meeting of Abstracts from the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, as published in Journal of Heart and Lung Transplantation. Montreal, Canada: Elsevier.
    DOI

  • Theses
    Year Citation
    2003 Kidd, S. (2003). Molecular epidemiology and characterisation of genetic structure to assess speciation within the Cryptococcus neoformans complex. (PhD Thesis, University of Sydney).

  • Internet Publications
    Year Citation
    2014 Kidd, S. E., & ellis, D. (2014). Australian Antifungal Susceptibility Trends in Yeasts: 2000-2013.. Australian Society of Antimicrobials.

 

 

Connect With Me
External Profiles

Other Links